Lok Sabha Question No. 4382 (UNSTARRED), answered on 2016-08-12
Subject: Anti-Microbial Drug Resistance Data
Ministry: HEALTH AND FAMILY WELFARE
Asked by: FEROZE VARUN GANDHI

## GOVERNMENT OF INDIA MINISTRY OF HEALTH AND FAMILY WELFARE DEPARTMENT OF HEALTH RESEARCH

LOK SABHA UNSTARRED  QUESTION NO. 4382 TO BE ANSWERED ON 12 TH AUGUST, 2016

## ANTI - MICROBIAL DRUG RESIS TANCE DATA

## 4382. SHRI FEROZE VARUN GANDHI:

Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:

- (a) whether the Government has formulated any programme to provide the data related to -microbial drug resistance at hospital level to create awareness among patients;
- (b) if so, t he details thereof and if not, the reasons therefor along with the steps taken t and disseminate the above data;
- (c) whether any project have been proposed by Indian Council of Medical Research (ICMR), India Institute of Medical Sciences and C ntre for Disease Control and Prevention (CDP) in this regard;
- (d) if so, the details thereof; and
- (e) the other steps taken by the Government to tackle anti - microbial drug resistance?

## ANSWER

## THE MINISTER OF STATE IN THE MINISTRY OF HEALTH AND FAMILY WELFARE (SMT. ANUPRIYA PATEL)

- (a ) & ( b) : As informed by Indian Council of Medical Research (ICMR) collection of data o resistance patterns in six  pathogenic groups of public health importance,  throug Antimicrobial Resistance Surveillance and Research Network (AMRSN), was initiated in 201 The  data  collected  from  the  network  is  used  to  formulate  treatment  guidelines. Ministry  of Health  &  Family  Welfare,  Government  of  India  (MoHFW)  has  launched  the  National Programme on Containment of Antimicrobial Resistance (AMR) under the 12 th five year p lan. The main objectives of this programme are:
- i. To establish a countrywide network of Medical College laboratories to study pattern of resistance in common pathogens to different antimicrobials in diff geographical  areas.  To  use  this  surveillan ce  data  for  instituting  appropriate interventions.
- ii. To strengthen infection control in hospitals across the country to contain f spread of antimicrobial resistance.

Contd……..

- iii. To  generate  awareness  among  healthcare  providers  and  in  the  community regarding rationale use of antibiotics.

A  network  of  10  laboratories  has  been  established  in  different  locations  i country, under the programme , and the network will be expanded in a phased manner. AMR surveillance activity has been initiated at these sites and AMR data has started flow these  sites  to  National  Centre  for  Disease  Control  (NCDC).  The  AMR  trends  are  bei analyzed  at  NCDC.  A ntimicrobial  stewardship  training  activities  have  been  initiated different stakeholders such as doctors, pharmacists where the AMR data is being shar generate awareness about AMR problem.

## Source: (i) Indian Council of Medical Research, (ii) National Centre for Disease Control.

(c) & ( d) : As part of AMR surveillance network of ICMR, All India Institute of Medical Sciences (AIIMS) has received funding from Centre for Disease Control and Prevention (CDC) to strengthen infection control practices in hospitals. The funds obtained under this gra used to strengthen quality assurance component of AMR surveillance and strengthen infec control practices in six hospitals across the country (AIIMS, N ew Delhi; JIPMER, Pondicherry; PGIMER, Chandigarh; CMC, Vellore; P.D. Hinduja National Hospital and Medical Research Centre, Mumbai; and Assam Medical College). The study will provide evidence on the impa of implementation of strict infection control pra ctices in AMR in hospitals.

(e) : ICMR monitors the drug resistance in six pathogenic groups of India's public health importance,  through  six  nodal  centers  in  four  tertiary  care  hospitals:  AIIMS,  PGI Chandigarh,  CMC  Vellore  and  JIPMER  Pondicherry. The  centers  are  collecting  resistance patterns and molecular epidemiology data in following six pathogenic groups:

- i) Diarrheagenic bacterial organisms
2. ii) Enteric fever pathogens
3. iii) Enterobacteriaceae causing sepsis
4. iv) Gram negative non fermenters
- v) Gram positives including MRSA
6. vi) Fungal infections

In addition, ICMR has issued infection control guidelines to have stringent infection practices, which will reduce the infections in hospitals thereby reducing the antibiot c use.

Further, ICMR has also developed international collaborations for strengthening A capacity building in India. ICMR has signed a Memorandum of Understanding (MoU ) with the Research Council of Norway (RCN) which focuses on methods of assessment of disease burden of AMR and on developing human animal integrated surveillance. In collaboration with Nati Institute of Health, USA (NIH), ICMR is focusing on strengthe ning systems biology of AMR, molecular epidemiology of neonatal sepsis and clinical trials with new entities combinations.

……………..